Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 11 days ago
Share
A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A)
130 patients around the world
Available in
Chile
Merck Sharp & Dohme LLC
4
Research sites
130
Patients around the world
This study is for people with
Colorectal cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
View site
Manzano 343, Recoleta, Región Metropolitana, Santiago
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
View site
Manzano 343, Recoleta, Región Metropolitana, Santiago
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
View site
Hochstetter 298, Temuco
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
View site
Hochstetter 298, Temuco
Instituto Oncológico FALP - UIDO
Recruiting
View site
José Manuel Infante 805, Providencia, Región Metropolitana
Instituto Oncológico FALP - UIDO
Recruiting
View site
José Manuel Infante 805, Providencia, Región Metropolitana
Clínica San Carlos de Apoquindo - Red de Salud UC Christus
Recruiting
View site
Camino El Alba 12407, Las Condes, Santiago
Clínica San Carlos de Apoquindo - Red de Salud UC Christus
Recruiting
View site
Camino El Alba 12407, Las Condes, Santiago
See details
Contact us
Contact us
Sponsor
Merck Sharp & Dohme LLC
Conditions
Colorectal cancer
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06428409
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent